[Psychostimulants: An Overview].
Shintaro Fukumoto1, Eiji Imanari, Shinji Tomari
1Department of Neuropsychiatry, University of Fukui.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 17, 2023
Summary
Narcolepsy and attention-deficit/hyperactivity disorder (ADHD) treatments focus on regulating life rhythms and managing symptoms. Psychostimulants are key for hypersomnia and moderate to severe ADHD, with specific ADHD medications approved in Japan.
Area of Science:
- Pharmacology
- Neurology
- Psychiatry
Context:
- Narcolepsy treatment necessitates regulating life rhythms.
- Attention-deficit/hyperactivity disorder (ADHD) management integrates psychosocial approaches with pharmacotherapy for moderate to severe symptoms.
Purpose:
- To outline the pharmacological and psychosocial strategies for managing narcolepsy and ADHD.
- To identify psychostimulant medications used in treating hypersomnia and ADHD.
Summary:
- Psychostimulants like modafinil, methylphenidate, and pemoline are employed to address hypersomnia associated with narcolepsy.
- In Japan, specific psychostimulants, including osmotic-release oral system methylphenidate and lisdexamfetamine dimesylate, are approved for ADHD treatment and distributed through a specialized system.
Impact:
- Provides an overview of current treatment paradigms for narcolepsy and ADHD.
- Highlights the role of psychostimulants in managing core symptoms of these neurological and psychiatric conditions.
More Related Videos
Related Concept Videos
01:28An Overview of Psychoactive Drugs
264
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
264
01:29Stimulants
258
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
258
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
293
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
293
01:22CNS Stimulants: Psychedelic Agents
198
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
198
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
01:28Adrenergic Agonists: Mixed-Action Agents
794
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
794